Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$365M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$297M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$290M |
| 5 |
Applied Materials
AMAT
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$290M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Johnson Controls International
JCI
|
+$275M |
| 4 |
L3Harris
LHX
|
+$235M |
| 5 |
Visa
V
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.75% |
| 2 | Industrials | 11.17% |
| 3 | Healthcare | 8.52% |
| 4 | Consumer Discretionary | 7.23% |
| 5 | Financials | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
MBIA
MBI
$250M
| $209K | ﹤0.01% |
+28,969
| New | +$241K |
|
2002
Pinnacle West Capital
PNW
$11.8B
| $208K | ﹤0.01% |
2,818
-335,002
| -99% | -$26.6M |
|
2003
Nurix Therapeutics
NRIX
$2.73B
| $207K | ﹤0.01% |
+26,275
| New | +$240K |
|
2004
Teradata
TDC
$2.56B
| $206K | ﹤0.01% |
4,585
-339,123
| -99% | -$16.6M |
|
2005
Intapp
INTA
$3.13B
| $205K | ﹤0.01% |
6,109
-42,516
| -87% | -$1.55M |
|
2006
RingCentral
RNG
$5.6B
| $204K | ﹤0.01% |
6,893
-340
| -5% | -$11.3K |
|
2007
Arlo Technologies
ARLO
$1.41B
| $204K | ﹤0.01% |
+19,787
| New | +$210K |
|
2008
Casella Waste Systems
CWST
$6.03B
| $203K | ﹤0.01% |
2,657
-82
| -3% | -$6.72K |
|
2009
Arcutis Biotherapeutics
ARQT
$3.11B
| $202K | ﹤0.01% |
+38,069
| New | +$324K |
|
|
SCU
2010
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $202K | ﹤0.01% |
+17,420
| New | +$191K |
|
2011
CAE Inc
CAE
$7.96B
| $201K | ﹤0.01% |
8,614
-48,685
| -85% | -$1.13M |
|
2012
Itron
ITRI
$4.32B
| $201K | ﹤0.01% |
+3,311
| New | +$227K |
|
2013
Stagwell
STGW
$2.17B
| $201K | ﹤0.01% |
+42,757
| New | +$253K |
|
2014
Ecolab
ECL
$80.4B
| $200K | ﹤0.01% |
1,183
-279,395
| -100% | -$50.8M |
|
2015
PUT
ChargePoint
CHPT
$153M
| $199K | ﹤0.01% |
2,000
| – | – |
|
2016
Coursera
COUR
$1.59B
| $198K | ﹤0.01% |
10,582
-64,663
| -86% | -$1.03M |
|
2017
Garrett Motion
GTX
$4.82B
| $197K | ﹤0.01% |
+24,999
| New | +$192K |
|
|
HTT
2018
High Templar Tech Ltd
HTT
$393M
| $190K | ﹤0.01% |
+89,800
| New | +$198K |
|
|
IMGN
2019
DELISTED
Immunogen Inc
IMGN
| $189K | ﹤0.01% |
11,920
-1,020,659
| -99% | -$17M |
|
2020
Anika Therapeutics
ANIK
$286M
| $187K | ﹤0.01% |
+10,054
| New | +$209K |
|
2021
Capitol Federal Financial
CFFN
$1.05B
| $186K | ﹤0.01% |
+38,991
| New | +$230K |
|
|
HSHP
2022
Himalaya Shipping
HSHP
$780M
| $185K | ﹤0.01% |
+38,298
| New | +$205K |
|
2023
ReNew
RNW
$2.48B
| $185K | ﹤0.01% |
+34,060
| New | +$201K |
|
|
SHYF
2024
DELISTED
The Shyft Group
SHYF
| $182K | ﹤0.01% |
+12,166
| New | +$205K |
|
2025
Cellebrite
CLBT
$2.88B
| $181K | ﹤0.01% |
+23,700
| New | +$178K |
|
Similar funds
Dmitry Balyasny's Q3 2023 Portfolio in Review
As of Q3 2023, Dmitry Balyasny held 2,899 positions worth $49B, up 7.8% from $45.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny deployed $4.13B of net new capital in Q3 2023, opening 681 new positions and adding to 729 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was McDonald's, an estimated $290M trimmed.
- Dmitry Balyasny's largest Q3 2023 buy was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $365M increase.
- Dmitry Balyasny's biggest Q3 2023 reduction was McDonald's, cutting an estimated $290M.
- Dmitry Balyasny fully exited Life Storage, Inc. in Q3 2023, selling an estimated $165M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $49B portfolio in Q3 2023.
- Dmitry Balyasny opened 681 new positions and closed 701 in Q3 2023.
- Dmitry Balyasny's portfolio value rose 7.8% quarter-over-quarter to $49B.
Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.